Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	cytoplasmic periphery of the nuclear pore complex	RGPD4 RGPD3 RGPD8	6.98e-05	8	229	3	GO:1990723
GeneOntologyCellularComponent	nuclear pore cytoplasmic filaments	RGPD4 RGPD3 RGPD8	1.47e-04	10	229	3	GO:0044614
Domain	-	MYCBP2 RCBTB2 UBR5 IBTK HERC5	5.18e-06	22	223	5	2.130.10.30
Domain	Grip	RGPD4 RGPD3 RGPD5 RGPD8	6.11e-06	11	223	4	SM00755
Domain	GRIP	RGPD4 RGPD3 RGPD5 RGPD8	6.11e-06	11	223	4	PF01465
Domain	RCC1/BLIP-II	MYCBP2 RCBTB2 UBR5 IBTK HERC5	6.55e-06	23	223	5	IPR009091
Domain	Ran_BP1	RGPD4 RGPD3 RGPD5 RGPD8	9.08e-06	12	223	4	PF00638
Domain	RANBD1	RGPD4 RGPD3 RGPD5 RGPD8	9.08e-06	12	223	4	PS50196
Domain	GRIP_dom	RGPD4 RGPD3 RGPD5 RGPD8	9.08e-06	12	223	4	IPR000237
Domain	GRIP	RGPD4 RGPD3 RGPD5 RGPD8	9.08e-06	12	223	4	PS50913
Domain	RanBD	RGPD4 RGPD3 RGPD5 RGPD8	1.30e-05	13	223	4	SM00160
Domain	Ran_bind_dom	RGPD4 RGPD3 RGPD5 RGPD8	1.30e-05	13	223	4	IPR000156
Domain	Rab_bind	RGPD4 RGPD3 RGPD8	5.67e-05	7	223	3	PF16704
Domain	GCC2_Rab_bind	RGPD4 RGPD3 RGPD8	5.67e-05	7	223	3	IPR032023
Domain	RCC1	MYCBP2 RCBTB2 IBTK HERC5	8.25e-05	20	223	4	PF00415
Domain	RCC1_1	MYCBP2 RCBTB2 IBTK HERC5	1.01e-04	21	223	4	PS00625
Domain	RCC1_2	MYCBP2 RCBTB2 IBTK HERC5	1.01e-04	21	223	4	PS00626
Domain	RCC1_3	MYCBP2 RCBTB2 IBTK HERC5	1.01e-04	21	223	4	PS50012
Domain	TPR-like_helical_dom	RGPD4 CLTCL1 BBS4 SMYD4 P3H1 RGPD3 CLTC RGPD5 RGPD8 TANC1 IFT122	1.17e-04	233	223	11	IPR011990
Domain	Reg_chr_condens	MYCBP2 RCBTB2 IBTK HERC5	1.22e-04	22	223	4	IPR000408
Domain	Clathrin_H-chain_propeller_rpt	CLTCL1 CLTC	1.42e-04	2	223	2	IPR022365
Domain	Clathrin-link	CLTCL1 CLTC	1.42e-04	2	223	2	PF09268
Domain	-	CLTCL1 CLTC	1.42e-04	2	223	2	2.130.10.110
Domain	DUF4062	NWD2 TEP1	1.42e-04	2	223	2	PF13271
Domain	Clathrin_heavy_chain	CLTCL1 CLTC	1.42e-04	2	223	2	IPR016341
Domain	Clathrin_H-chain_propeller_N	CLTCL1 CLTC	1.42e-04	2	223	2	IPR001473
Domain	Clathrin_H-chain_link/propller	CLTCL1 CLTC	1.42e-04	2	223	2	IPR016025
Domain	Clathrin_propel	CLTCL1 CLTC	1.42e-04	2	223	2	PF01394
Domain	DUF4062	NWD2 TEP1	1.42e-04	2	223	2	IPR025139
Domain	Clathrin_H-chain_linker_core	CLTCL1 CLTC	1.42e-04	2	223	2	IPR015348
Domain	Ank_3	ANK3 RFXANK TNKS	1.89e-04	10	223	3	PF13606
Domain	-	RGPD4 RGPD3 RGPD8	1.89e-04	10	223	3	1.10.220.60
Domain	-	RGPD4 CLTCL1 BBS4 SMYD4 P3H1 RGPD3 CLTC RGPD8 TANC1 IFT122	1.99e-04	207	223	10	1.25.40.10
Domain	Frizzled	FZD1 FZD7 FZD2	2.58e-04	11	223	3	IPR000539
Domain	Frizzled	FZD1 FZD7 FZD2	2.58e-04	11	223	3	PF01534
Domain	Frizzled	FZD1 FZD7 FZD2	2.58e-04	11	223	3	SM01330
Domain	Clathrin_H-chain_linker	CLTCL1 CLTC	4.22e-04	3	223	2	IPR012331
Domain	PINCH	LIMS2 LIMS1	4.22e-04	3	223	2	IPR017351
Domain	CLH	CLTCL1 CLTC	4.22e-04	3	223	2	SM00299
Domain	GPAT/DHAPAT	GNPAT GPAM	4.22e-04	3	223	2	IPR022284
Domain	ARM-type_fold	RALGAPA1 CLTCL1 NBEAL1 ITPR1 CLTC NIPBL COPB1 UBR4 VIRMA MROH2B WDFY3 STAG2	8.08e-04	339	223	12	IPR016024
Domain	Argonaute_N	AGO3 AGO1	8.38e-04	4	223	2	IPR032474
Domain	Argonaute_Mid_dom	AGO3 AGO1	8.38e-04	4	223	2	IPR032473
Domain	ArgoL2	AGO3 AGO1	8.38e-04	4	223	2	IPR032472
Domain	ArgoN	AGO3 AGO1	8.38e-04	4	223	2	PF16486
Domain	ArgoMid	AGO3 AGO1	8.38e-04	4	223	2	PF16487
Domain	ArgoL2	AGO3 AGO1	8.38e-04	4	223	2	PF16488
Domain	Frizzled/SFRP	FZD1 FZD7 FZD2	8.38e-04	16	223	3	IPR015526
Domain	Spc97_Spc98	TUBGCP4 TUBGCP6	1.39e-03	5	223	2	PF04130
Domain	GCP	TUBGCP4 TUBGCP6	1.39e-03	5	223	2	IPR007259
Domain	DUF4704	NBEAL1 WDFY3	1.39e-03	5	223	2	IPR031570
Domain	DUF4704	NBEAL1 WDFY3	1.39e-03	5	223	2	PF15787
Domain	DUF1785	AGO3 AGO1	1.39e-03	5	223	2	SM01163
Domain	FRI	FZD1 FZD7 FZD2	1.65e-03	20	223	3	SM00063
Pathway	KEGG_PRIMARY_IMMUNODEFICIENCY	AICDA PTPRC BTK RFXANK CD79A IL2RG	3.42e-06	35	170	6	M4085
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ZSWIM8 ACACA MYCBP2 RPS12 PSMD12 PNPT1 FASN UBR5 CLTC PLEC HSPA2 NIPBL COPB1 PRDX4 UBR4 HNRNPUL1 THOC2 VIRMA IGF2BP3 UBE2O UTP4 ASNS STAG2 HERC5	1.76e-11	653	232	24	22586326
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RGPD4 KRT72 INTU CLTCL1 PYROXD1 KRT74 RPS12 TOMM20 PTGFR FER1L6 ACSL4 DES FASN TNRC18 GSPT2 STXBP1 RGPD3 CLTC KDR PLEC RAB39B DMD TASOR HSPA2 NIPBL RGPD5 RGPD8 PRDX4 UBR4 KRBA2 RNF17 SF3B3 DOK4 IFT122 STAG2	4.12e-11	1442	232	35	35575683
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	NLRP11 MYO7B FER1L6 CLTC KDR ALB PLEC DMD RGPD8 PCARE THOC2 VIRMA IGF2BP3 SF3B3 PPIP5K1	6.72e-11	234	232	15	36243803
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DAB2IP RGPD4 ARHGAP32 MYCBP2 ZNF462 CNTNAP5 UBA1 AGO3 UBR5 RGPD3 CLTC LRRC7 NIPBL CAP2 DRG2 RGPD8 ANK3 UACA UBR4 SPATA20 VIRMA FRY UBE2O AGO1 AKAP9 PRKAR1B TNKS WDFY3	7.93e-11	963	232	28	28671696
Pubmed	Defining the membrane proteome of NK cells.	CLTCL1 MYCBP2 CDS2 RPS12 PSMD12 TUBGCP4 GALNT7 MELK ITPR1 ACSL4 FASN PTPRC AGO3 UBR5 GLG1 P3H1 CLTC COG5 HSPA2 GNPAT DRG2 COPB1 UBR4 DGKE TUBGCP6 FADS1 IFT122 IL2RG STAG2 RHOT1	3.12e-10	1168	232	30	19946888
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RALGAPA1 ATP6V0A1 MYCBP2 ATAD5 RPS12 TMEM214 ITPR1 PNPT1 UBR5 GLG1 P3H1 CLTC HSPA2 TARS1 DRG2 ANK3 UACA PRDX4 UBR4 DGKE HNRNPUL1 TUBGCP6 UBE2O SF3B3 AKAP9 UTP4 ASNS PRKAR1B TANC1 IFT122 HERC5	2.11e-08	1487	232	31	33957083
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	FASN GLG1 CLTC ALB PLEC UACA COPB1 UBR4 THBS1 PALLD CRBN	4.51e-08	182	232	11	31067453
Pubmed	Amyloid Precursor Protein (APP) May Act as a Substrate and a Recognition Unit for CRL4CRBN and Stub1 E3 Ligases Facilitating Ubiquitination of Proteins Involved in Presynaptic Functions and Neurodegeneration.	ATP6V0A1 PSMD12 UBA1 UBR5 UBR4 UBE2O FBXO21 CRBN	6.03e-08	79	232	8	27325702
Pubmed	Complex genomic rearrangements lead to novel primate gene function.	RGPD4 RGPD3 RGPD5 RGPD8	6.65e-08	7	232	4	15710750
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	LRWD1 ACACA TOMM20 PSMD12 FASN STXBP1 UBR5 RGPD3 CLTC NIPBL DRG2 COPB1 UBR4 VIRMA IGF2BP3 LIMS1 UTP4 PRIM2 ASNS RHOT1	6.74e-08	704	232	20	29955894
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ARHGAP32 ATAD5 CDS2 FER1L6 ACSL4 STXBP1 NIPBL KNL1 EXOC6 SATB2 UBR4 RFX1 BABAM2 VIRMA THBS1 SS18L1 WDFY3 IL17RD STAG2	7.02e-08	638	232	19	31182584
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	RGPD4 LRWD1 TUBGCP4 ITPR1 PHKA2 FASN UBA1 UBR5 P3H1 RGPD3 CLTC COG5 NIPBL KNL1 RGPD5 RGPD8 UACA COPB1 HNRNPUL1 TUBGCP6 THBS1 IGF2BP3 SF3B3 SYTL4 STAG2 CRBN	7.29e-08	1155	232	26	20360068
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RGPD4 ACACA MYCBP2 ZNF462 FASN UBR5 RGPD3 PLEC TASOR KNL1 SATB2 DRG2 RGPD8 UBR4 RFX1	1.68e-07	418	232	15	34709266
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DAB2IP RGPD4 ARHGAP32 ACACA MYCBP2 PSMD12 NDRG3 ITPR1 TNRC18 UBA1 GSPT2 STXBP1 GLG1 RGPD3 CLTC LRRC7 PLEC HSPA2 RGPD8 ANK3 UBR4 IDH3G UBE2O FADS1 PRKAR1B	2.12e-07	1139	232	25	36417873
Pubmed	Molecular cloning, differential expression, and chromosomal localization of human frizzled-1, frizzled-2, and frizzled-7.	FZD1 FZD7 FZD2	2.93e-07	3	232	3	9813155
Pubmed	Frizzled proteins are colonic epithelial receptors for C. difficile toxin B.	FZD1 FZD7 FZD2	2.93e-07	3	232	3	27680706
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	RGPD4 LRWD1 ACACA MYCBP2 RPS12 PSMD12 FASN UBA1 UBR5 YAE1 RGPD3 CLTC HSPA2 TARS1 RGPD5 RGPD8 COPB1 PRDX4 UBR4 DGKE HNRNPUL1 IDH3G THOC2 IGF2BP3 SF3B3 ASNS	3.71e-07	1257	232	26	37317656
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DAB2IP LRWD1 CLTCL1 ACACA MYCBP2 PLXND1 FZD1 FZD7 FASN TNRC18 NUAK1 PLEC UBR4 KAT6A SPATA20 TEP1 BABAM2 DOK4 USP40 HMGXB3 TANC1 WDFY3 MAPKBP1 IL17RD	4.55e-07	1105	232	24	35748872
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	RPS12 ITPR1 BTK PLEC TRMT61B NIPBL COPB1 THOC2 RFX1 IGF2BP3 SF3B3 UTP4 STAG2	5.60e-07	340	232	13	29478914
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	CMBL UAP1 CLTCL1 ACACA MYCBP2 PSMD12 FASN GLG1 CLTC PLEC HSPA2 TARS1 ANK3 COPB1 PRDX4 UBR4 XPNPEP1 HNRNPUL1 SF3B3 AKAP9	5.85e-07	807	232	20	30575818
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	MYCBP2 AGO3 UBR5 PLEC PRDX4 AGO1 AKAP9	7.94e-07	76	232	7	27542412
Pubmed	Germinal center centroblasts transition to a centrocyte phenotype according to a timed program and depend on the dark zone for effective selection.	AICDA CXCR4 CD79A	1.17e-06	4	232	3	24184055
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	DAB2IP FBXW12 CDS2 BBS4 PRAMEF1 GALNT7 ITPR1 PTPRC GLG1 CLTC PLEC COG5 TASOR ANK3 PRAMEF22 ANKRD50 THOC2 LIMS1 KIAA0040 HMGXB3 IL17RD CCDC171 STAG2	1.19e-06	1084	232	23	11544199
Pubmed	Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons.	RGPD4 RGPD3 RGPD8 ANK3	1.32e-06	13	232	4	31427429
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ACACA VPS13C PLXND1 NDRG3 MKS1 UBR5 CLTC ALB TASOR TARS1 CDON ANK3 EFCAB6 COPB1 HNRNPUL1 ANKRD50 IGF2BP3 ARL5B SYTL4	1.38e-06	777	232	19	35844135
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	ACACA PSMD12 FASN UBA1 CLTC PLEC HSPA2 TARS1 COPB1 UBR4 HNRNPUL1 THOC2 UBE2O SF3B3 PRIM2 ASNS STAG2	1.61e-06	638	232	17	33239621
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ZSWIM8 DCHS2 ATP6V0A1 MYCBP2 STXBP1 CLTC ZBTB5 PLEC HSPA2 NIPBL TARS1 CAP2 ANK3 COPB1 UBR4 DNAAF9 HNRNPUL1 PLAAT3 THBS1 FRY UBE2O RORB TNKS IFT122 WDFY3	1.90e-06	1285	232	25	35914814
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	RGPD4 KRT72 CLTCL1 RPS12 PSMD12 ACSL4 DES FASN UBA1 UBR5 CLTC PLEC COPB1 UBR4 HNRNPUL1 IGF2BP3 FBXO21	1.94e-06	647	232	17	26618866
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGAPA1 VPS13C TOMM20 PLXND1 MELK NUAK1 MED12L ZBTB5 SATB2 ANKRD50 TUBGCP6 IBTK UBE2O SF3B3 HMGXB3	3.17e-06	529	232	15	14621295
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	CMBL KRT72 CLTCL1 KRT74 RPS12 PSMD12 FASN UBA1 CLTC RAB39B TRMT61B HSPA2 EPM2A UACA COPB1 PRDX4 HNRNPUL1 IGF2BP3 UBE2O SF3B3 AGO1 ASNS FBXO21	3.33e-06	1153	232	23	29845934
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	ACACA PSMD12 ACSL4 PNPT1 FASN UBA1 UBR5 COPB1 PRDX4 UBR4 THOC2 IGF2BP3 PRIM2 ASNS PALLD	3.55e-06	534	232	15	35032548
Pubmed	Proteomic Analysis of the Spinophilin Interactome in Rodent Striatum Following Psychostimulant Sensitization.	ATP6V0A1 PHYHIP ITPR1 FASN UBA1 STXBP1 CLTC ALB PLEC HSPA2 CAP2 ANK3 IDH3G	3.66e-06	403	232	13	30562941
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RALGAPA1 KRT72 ARHGAP32 ATP6V0A1 PHYHIP FASN UBA1 NWD2 STXBP1 AKR1B10 CLTC LRRC7 ALB PLEC DMD HSPA2 TARS1 ANK3 COPB1 VIRMA UBE2O SF3B3 AGO1 MCU TANC1 RHOT1	4.03e-06	1431	232	26	37142655
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	CLTCL1 RPS12 PSMD12 TUBGCP4 ITPR1 FASN UBR5 CXCR4 CLTC IFI44L TRMT61B COG5 HSPA2 UACA COPB1 PRDX4 UBR4 DGKE HNRNPUL1 THOC2 IGF2BP3 FADS1 SF3B3 ASNS STAG2 HERC5	4.50e-06	1440	232	26	30833792
Pubmed	FZD2 regulates limb development by mediating β-catenin-dependent and -independent Wnt signaling pathways.	FZD1 FZD7 FZD2	5.77e-06	6	232	3	36867021
Pubmed	Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.	ACACA KRT74 RPS12 TOMM20 FASN CLTC ALB PLEC DMD HSPA2 HNRNPUL1 THBS1 IGF2BP3 CRBN	5.94e-06	488	232	14	31324722
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	RPS12 PSMD12 FASN UBA1 AGO3 CLTC PLEC TARS1 COPB1 HNRNPUL1 IGF2BP3 SF3B3 PALLD CRBN	6.82e-06	494	232	14	26831064
Pubmed	Isolation of a unique hepatic stellate cell population expressing integrin α8 from embryonic mouse livers.	DES PTPRC KDR ALB	6.91e-06	19	232	4	29665133
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	RGPD4 ATAD5 ACSL4 FASN RGPD3 PLEC RGPD8 COPB1 BABAM2 VIRMA IGF2BP3 LIMS1	8.24e-06	370	232	12	22922362
Pubmed	The sperm-associated antigen 6 interactome and its role in spermatogenesis.	MYCBP2 BBS4 PSMD12 NIPBL COPB1 GPAM BABAM2 PRIM2 STAG2	8.39e-06	199	232	9	31146259
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	DAB2IP RALGAPA1 ARHGAP32 MYCBP2 ATAD5 PSMD12 ITPR1 ACSL4 UBA1 PTPRC P3H1 CLTC DMD HSPA2 CAP2 KNL1 ANK3 DUSP19 AKAP9 PRIM2 TANC1	8.58e-06	1049	232	21	27880917
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	TUBGCP4 ITPR1 PHKA2 SMYD4 RAD54B TASOR GNPAT GPAM ANKRD50 IBTK MCU TANC1 IFT122 PALLD CWF19L1 RHOT1	8.85e-06	650	232	16	38777146
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	RGPD4 CLTCL1 MYCBP2 FASN CLTC HSPA2 THOC2 VIRMA SF3B3	9.47e-06	202	232	9	24639526
Pubmed	Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	9037092
Pubmed	Nup358, a nucleoporin, functions as a key determinant of the nuclear pore complex structure remodeling during skeletal myogenesis.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	21205196
Pubmed	Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	24403063
Pubmed	Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	23536549
Pubmed	Identification of RanBP2- and kinesin-mediated transport pathways with restricted neuronal and subcellular localization.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	12191015
Pubmed	Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	22821000
Pubmed	Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	11353387
Pubmed	Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	30944974
Pubmed	Nucleoporin Nup358 drives the differentiation of myeloid-biased multipotent progenitors by modulating HDAC3 nuclear translocation.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	38838144
Pubmed	Retina-specifically expressed novel subtypes of bovine cyclophilin.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	7559465
Pubmed	Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	17372272
Pubmed	Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl cis-trans Isomerase and Chaperone Activities of Its Cyclophilin Domain.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	38657106
Pubmed	Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	18949001
Pubmed	Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	25187515
Pubmed	Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	8603673
Pubmed	Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	26632511
Pubmed	Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	23818861
Pubmed	Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.	RGPD4 RGPD3 RGPD8	1.01e-05	7	232	3	20682751
Pubmed	FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.	UAP1 LRWD1 ACACA PSMD12 GLG1 PLEC PRIM2 ASNS HERC5	1.39e-05	212	232	9	33462405
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	ABCA12 FASN STXBP1 GLG1 PLEC TEP1 THBS1 OSMR HERC5	1.50e-05	214	232	9	22199357
Pubmed	ATP-citrate lyase deficiency in the mouse.	ACACA FZD1 FASN GPAM	1.55e-05	23	232	4	14662765
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	UAP1 LRWD1 ATAD5 RPS12 TMEM214 CLTC NIPBL CAP2 SATB2 EPM2A COPB1 MED9 THOC2 ASNS	1.60e-05	533	232	14	30554943
Pubmed	Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.	DES DMD ANK3	1.60e-05	8	232	3	28826662
Pubmed	Sequence requirement and subtype specificity in the high-affinity interaction between human frizzled and dishevelled proteins.	FZD1 FZD7 FZD2	1.60e-05	8	232	3	19388021
Pubmed	The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.	RGPD4 RGPD3 RGPD8	1.60e-05	8	232	3	21670213
Pubmed	Germinal Center Selection and Affinity Maturation Require Dynamic Regulation of mTORC1 Kinase.	AICDA PTPRC CD79A	1.60e-05	8	232	3	28636954
Pubmed	Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.	RGPD4 RGPD3 RGPD8	1.60e-05	8	232	3	27412403
Pubmed	Mice lacking Ran binding protein 1 are viable and show male infertility.	RGPD4 RGPD3 RGPD8	1.60e-05	8	232	3	21310149
Pubmed	The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2.	RGPD4 RGPD3 RGPD8	1.60e-05	8	232	3	22262462
Pubmed	Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.	RGPD4 RGPD3 RGPD8	1.60e-05	8	232	3	28745977
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	FASN TNRC18 CLTC PLEC PLD4 KAT6A KHDC4 RNF227 TRMU THBS1 HMGXB3	1.62e-05	332	232	11	37433992
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	FASN CLTC ALB PLEC NIPBL COPB1 UBR4 SF3B3 PALLD STAG2	1.62e-05	272	232	10	31010829
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	RGPD4 RPS12 FASN RGPD3 CLTC PLEC DMD HSPA2 TARS1 RGPD5 RGPD8 ANK3 UBR4 KRBA2 HNRNPUL1 SF3B3 AGO1 PALLD	1.68e-05	844	232	18	25963833
Pubmed	Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.	RGPD4 UBA1 GLG1 P3H1 RGPD3 DRG2 RGPD8 SF3B3 CRBN	2.31e-05	226	232	9	37839992
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 INTU ACACA MYCBP2 VPS13C ATP9B GALNT7 ZNF462 TNRC18 LRRC7 CAP2 RAD52 ANK3 UACA PCDH11Y KAT6A TEP1 BABAM2 USP40 PRKAR1B TANC1 IFT122 FBXO21 CYP4F11 STAG2	2.36e-05	1489	232	25	28611215
Pubmed	Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.	RGPD4 RGPD3 RGPD8	2.39e-05	9	232	3	28100513
Pubmed	Direct interaction of Frizzled-1, -2, -4, and -7 with PDZ domains of PSD-95.	FZD1 FZD7 FZD2	2.39e-05	9	232	3	12067714
Pubmed	Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and function.	RGPD4 RGPD3 RGPD8	2.39e-05	9	232	3	17887960
Pubmed	Frizzled 2 and frizzled 7 function redundantly in convergent extension and closure of the ventricular septum and palate: evidence for a network of interacting genes.	FZD1 FZD7 FZD2	2.39e-05	9	232	3	23095888
Pubmed	The cyclophilin-like domain mediates the association of Ran-binding protein 2 with subunits of the 19 S regulatory complex of the proteasome.	RGPD4 RGPD3 RGPD8	2.39e-05	9	232	3	9733766
Pubmed	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	RGPD4 RGPD3 RGPD8	2.39e-05	9	232	3	18394993
Pubmed	The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain.	RGPD4 RGPD3 RGPD8	2.39e-05	9	232	3	11553612
Pubmed	The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.	RGPD4 RGPD3 RGPD8	2.39e-05	9	232	3	10601307
Pubmed	Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.	RGPD4 RGPD3 RGPD8	2.39e-05	9	232	3	28877029
Pubmed	A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals.	FZD1 FZD7 FZD2	2.39e-05	9	232	3	9707618
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZSWIM8 NWD2 UBR4 TANC1 WDFY3 FBXO21	2.66e-05	87	232	6	12465718
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	KRT72 KRT74 VPS13C PRAMEF1 MKS1 STXBP1 ALB PLEC HSPA2 PRAMEF22 THBS1 UTP4 PRIM2 IFT122	2.96e-05	564	232	14	21565611
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	CLTCL1 PLXND1 FASN UBR5 CLTC ALB PLEC SF3B3 STAG2	3.14e-05	235	232	9	30258100
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	LRWD1 ACACA MYCBP2 ATAD5 RPS12 UBA1 AGO3 PLEC UACA IBTK IGF2BP3 SF3B3 AGO1 SYTL4 UTP4 PALLD	3.28e-05	724	232	16	36232890
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	ACACA MYCBP2 RPS12 PSMD12 PHKA2 FASN UBA1 UBR5 CLTC PLEC HSPA2 TARS1 ANK3 COPB1 PRDX4 UBR4 HNRNPUL1 IGF2BP3 UBE2O SF3B3 ASNS	3.28e-05	1149	232	21	35446349
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYCBP2 ZNF462 DES CLTC MED12L PLEC UACA ANKRD50 LIMS1 AKAP9 TNKS PALLD STAG2	3.35e-05	497	232	13	23414517
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	CMBL TMEM241 AICDA FBXW12 CDS2 PRAMEF1 MELK MKS1 ACSL4 PNPT1 SMYD4 AGO3 GLG1 PRAMEF22 XPNPEP1 VIRMA AGO1 AKAP9 CYP2R1 CGRRF1 HMGXB3 RHOT1	3.39e-05	1242	232	22	30973865
Pubmed	Parkin ubiquitinates and promotes the degradation of RanBP2.	RGPD4 RGPD3 RGPD8	3.40e-05	10	232	3	16332688
Pubmed	Cytoskeletal disruption and small heat shock protein translocation immediately after lengthening contractions.	DES PLEC DMD	3.40e-05	10	232	3	14627610
Pubmed	The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.	RGPD4 RGPD3 RGPD8	3.40e-05	10	232	3	27160050
Pubmed	Expression of Frizzled genes in developing and postnatal hair follicles.	FZD1 FZD7 FZD2	3.40e-05	10	232	3	15245425
Pubmed	Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin.	RGPD4 RGPD3 RGPD8	3.40e-05	10	232	3	8857542
Interaction	SIRT7 interactions	ZSWIM8 ACACA MYCBP2 RPS12 PSMD12 PNPT1 FASN UBR5 CLTC PLEC HSPA2 NIPBL COPB1 PRDX4 UBR4 HNRNPUL1 THOC2 VIRMA IGF2BP3 UBE2O UTP4 ASNS STAG2 HERC5	4.51e-06	744	229	24	int:SIRT7
Cytoband	2p23.2	TRMT61B PCARE BABAM2	3.51e-05	13	232	3	2p23.2
GeneFamily	G protein-coupled receptors, Class F frizzled	FZD1 FZD7 FZD2	9.70e-05	11	155	3	286
GeneFamily	LIM zinc finger domain containing\|LIM domain containing	LIMS2 LIMS1	4.33e-04	4	155	2	1163
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	RGPD4 BBS4 RGPD3 RGPD5 RGPD8 TANC1	4.70e-04	115	155	6	769
GeneFamily	HRAS like suppressor family	PLAAT3 PLAAT5	7.18e-04	5	155	2	1227
GeneFamily	X-linked mental retardation\|Angiotensin receptors	ACSL4 RAB39B DMD THOC2	1.10e-03	53	155	4	103
GeneFamily	Ankyrin repeat domain containing	BANK1 ANK3 UACA ANKRD50 IBTK RFXANK TNKS TANC1	1.17e-03	242	155	8	403
GeneFamily	Ubiquitin protein ligase E3 component n-recognins	UBR5 UBR4	1.49e-03	7	155	2	785
GeneFamily	WD repeat domain containing	LRWD1 NBEAL1 FBXW12 TEP1 UTP4 IFT122 WDFY3 MAPKBP1	1.93e-03	262	155	8	362
GeneFamily	Argonaute/PIWI family	AGO3 AGO1	1.98e-03	8	155	2	408
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL1 WDFY3	2.53e-03	9	155	2	1230
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MYCBP2 CDS2 MELK ITPR1 ACSL4 NUAK1 UBR5 DMD COG5 TASOR NIPBL CAP2 SATB2 KAT6A THOC2 IBTK IGF2BP3 AKAP9 PRIM2 TNKS WDFY3 OSMR STAG2	2.16e-06	856	230	23	M4500
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	RALGAPA1 ACACA PYROXD1 BBS4 ATP9B TUBGCP4 GALNT7 ACSL4 GSPT2 UBR5 BTK TRMT61B TASOR NIPBL BANK1 GNPAT EPM2A COPB1 PRDX4 THOC2 BABAM2 PLAAT3 IBTK LIMS1 ZNF713 ASNS RHOT1	9.44e-06	1215	230	27	M41122
Coexpression	DOANE_RESPONSE_TO_ANDROGEN_DN	TRAF5 PLXND1 ITPR1 CXCR4 RAD54B ZNF322 THBS1 AKAP9 IFT122 PALLD STAG2	1.05e-05	242	230	11	M12816
Coexpression	GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN	CMBL PYROXD1 PTPRC GNPAT COPB1 KAT6A VIRMA PLAAT3 IGF2BP3 STAG2	1.17e-05	200	230	10	M7025
Coexpression	GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP	ACACA PHYHIP UBA1 UBR5 CMAHP HNRNPUL1 FRY UBE2O PPIP5K1	3.21e-05	180	230	9	M357
Coexpression	TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING	RGPD4 ATP6V0A1 GLG1 RGPD3 RGPD8	3.65e-05	43	230	5	MM3857
Coexpression	GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	TRAF5 ABCA12 RPS12 HAO1 CXCR4 PLEC BANK1 KAT6A FRY	6.74e-05	198	230	9	M4451
Coexpression	GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	TRAF5 ABCA12 MEP1A CXCR4 BANK1 CAP2 SATB2 KAT6A FRY	7.00e-05	199	230	9	M4444
Coexpression	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	AICDA PYROXD1 TOMM20 RCBTB2 PSMD12 TUBGCP4 ITPR1 ADM PTPRC GLG1 TMPRSS3 CLTC PRDX4 KAT6A XPNPEP1 BABAM2	7.24e-05	590	230	16	M16066
Coexpression	GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN	TXK PTPRC YAE1 CLTC CAP2 EXOC6 COPB1 HMGXB3 FBXO21	7.28e-05	200	230	9	M7058
Coexpression	GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP	ATP6V0A1 PLXND1 GALNT7 STXBP1 NUAK1 TRMT61B LIMS1 WDFY3 FBXO21	7.28e-05	200	230	9	M3404
Coexpression	GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP	ABCA12 NDRG3 CAP2 GNPAT CENPS LIMS1 TNKS FZD2 PALLD	7.28e-05	200	230	9	M9584
Coexpression	ONKEN_UVEAL_MELANOMA_UP	TRAF5 TMEM214 GALNT7 FZD7 TRAPPC13 FASN PTPRC UBR5 CXCR4 RAD54B KDR PRDX4 SPATA20 FRY FADS1 AKAP9 PHF11 HMGXB3 RHOT1	7.64e-05	790	230	19	M12490
ToppCell	facs-Marrow-T-cells-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TXK PTPRC CXCR4 ALB CMAHP KLRC2 KLRC3 BANK1 KIAA0040 CD79A IL2RG	3.96e-09	185	232	11	e1fd0a807def8c2127194108b1a30c6de7024292
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRAF5 MYO7B RPS12 PTPRC BANK1 COL19A1 LIMS2 ABCA6 KIAA0040 CD79A IL2RG	5.83e-09	192	232	11	5d6569b0f879729aa89d4498c9c886ac9050be13
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 VPS13C PTPRC NIPBL KAT6A HNRNPUL1 TEP1 THBS1 CD79A STAG2	4.31e-08	182	232	10	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TXK PTPRC CXCR4 CMAHP KLRC2 KLRC3 BANK1 KIAA0040 CD79A IL2RG	4.78e-08	184	232	10	b12fb85a064f715a4f0ada1df8e422c359b573cf
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-naive_B_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TRAF5 MYO7B PTPRC BANK1 PLD4 COL19A1 LIMS2 KIAA0040 CD79A IL2RG	7.87e-08	194	232	10	4a4cc61193344bb151439f63d0584abddde47cf0
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 VPS13C PTPRC TASOR NIPBL KAT6A HNRNPUL1 THBS1 STAG2	5.52e-07	184	232	9	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	wk_08-11-Hematologic_Lymphocytic-B-Immature_B\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	MYO7B PTPRC CXCR4 BTK TMPRSS3 BANK1 PLD4 CD79A IL2RG	5.52e-07	184	232	9	e6669a1b7ea7e4f8e094add5117689470019d85d
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 VPS13C PTPRC NIPBL KAT6A HNRNPUL1 THBS1 CD79A STAG2	5.77e-07	185	232	9	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ATP6V0A1 MYO7B VPS13C ITPR1 BTK BANK1 COL19A1 UACA CD79A	6.90e-07	189	232	9	e2bb5900d210386b7b74938e7a3636d0c7ba1bcf
ToppCell	wk_15-18-Hematologic_Lymphocytic-B-Immature_B\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYO7B PTPRC CXCR4 BTK BANK1 PLD4 LIMS2 KIAA0040 CD79A	6.90e-07	189	232	9	5776f842b3047d21ccdc44db884bfd210823c7da
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ATP6V0A1 MYO7B ITPR1 CXCR4 BTK BANK1 COL19A1 UACA CD79A	7.21e-07	190	232	9	441770ce7b3c81f36f5b15b8e51794f736462457
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRAF5 RPS12 PTPRC CXCR4 BTK BANK1 PLD4 COL19A1 CD79A	7.54e-07	191	232	9	8ab68407acb8062614397f139439c7617030d969
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRAF5 RPS12 PTPRC CXCR4 BTK BANK1 PLD4 COL19A1 CD79A	7.54e-07	191	232	9	51903c1c5e984bb7bbef0d67ee760256fc891f75
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRAF5 VPS13C PTPRC BANK1 PLD4 COL19A1 LIMS2 KIAA0040 CD79A	7.54e-07	191	232	9	a073d58154c801ec499fd969f42b7f1ee7f15d79
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-Immature_B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MYO7B PTPRC CXCR4 BTK BANK1 PLD4 LIMS2 KIAA0040 CD79A	8.58e-07	194	232	9	f957cec2f309d726e095d18a7da32789dca92a36
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-8\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYO7B CXCR4 DMD BANK1 PLD4 COL19A1 LIMS2 KIAA0040 CD79A	8.58e-07	194	232	9	e9c907b8ec4329946338cca5ce8e954fa2cec37b
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MYO7B PTPRC CXCR4 BTK BANK1 PLD4 COL19A1 CD79A IL2RG	9.75e-07	197	232	9	fd65020089baca78334cecddc96b7a65028c2b7c
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 ACACA DMD COG5 COL19A1 ANK3 MCU TANC1 WDFY3	1.02e-06	198	232	9	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	10x5'-Lung-Myeloid_Monocytic-Cycling_mono\|Lung / Manually curated celltypes from each tissue	CLTCL1 ATAD5 KNL1 VIRMA ASGR2 SS18L1 PPIP5K1 WDFY3	1.67e-06	156	232	8	63b8cf14361b282872bc1c5b65d9fbc83e81a089
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNT7 SMYD4 BTK MED12L LRRC7 BANK1 PLD4 CD79A	2.21e-06	162	232	8	e81dec1db8e5a808d96e58410c91961e5d065c94
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNT7 SMYD4 BTK MED12L LRRC7 BANK1 PLD4 CD79A	2.21e-06	162	232	8	d19b469f64c9064cfb82dadb6c8135e28949a02a
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNT7 SMYD4 BTK MED12L LRRC7 BANK1 PLD4 CD79A	2.21e-06	162	232	8	10c2aa047f33f48e4abe676236bbdb593079dd1d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 MELK RAD54B MED12L KNL1 FADS1 PRIM2 KBTBD12	2.77e-06	167	232	8	108ae6221c6edc63c0ec42c42471b3a15a594043
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITPR1 PTPRC CXCR4 BTK BANK1 PLD4 KIAA0040 CD79A	2.90e-06	168	232	8	063d0368d656962b335154c230bdcd9236e7c9ad
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITPR1 PTPRC CXCR4 BTK BANK1 PLD4 KIAA0040 CD79A	2.90e-06	168	232	8	eeb381b62c7ba263af96de1194ed59e57b6ca3ae
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITPR1 PTPRC CXCR4 BTK BANK1 PLD4 KIAA0040 CD79A	2.90e-06	168	232	8	a7c4251d8a83bc30196a444028a35c17c24dc291
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ARHGAP32 ITPR1 PTPRC CXCR4 BANK1 RGPD5 COL19A1 KAT6A	3.03e-06	169	232	8	c3a6179a64589a370108fea809b157839347759c
ToppCell	B_cell\|World / lung cells shred on cell class, cell subclass, sample id	NUGGC TRAF5 CXCR4 MED12L BANK1 PLD4 COL19A1 CD79A	3.17e-06	170	232	8	cec4090ba6a9c934d5f6f9e4aa7823f3713319b7
ToppCell	droplet-Limb_Muscle-nan-21m-Lymphocytic-B_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRC CXCR4 BTK BANK1 PLD4 CD79A KBTBD12 IL2RG	3.45e-06	172	232	8	62734d231290ca725276dc62faa2ac87bd1b37b8
ToppCell	facs-Marrow-T-cells\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TXK ADM ALB KLRC2 KLRC3 BANK1 CD79A IL2RG	3.60e-06	173	232	8	806f94f5c3ac836ddffc389d3c2cd7e4da7a608d
ToppCell	LPS-antiTNF-Lymphocytic_B-B_cells-B-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITPR1 PTPRC CXCR4 BTK BANK1 PLD4 KIAA0040 CD79A	3.76e-06	174	232	8	9eb3504f9340517ef5d056503044fbdb9ffeb714
ToppCell	droplet-Lung-nan-21m-Lymphocytic-Plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUGGC ZPBP2 RAB39B CMAHP PRDX4 ASNS CD79A KBTBD12	3.76e-06	174	232	8	3f4277763e312b46ebd4401ea4a2f5d4c850c768
ToppCell	LPS-antiTNF-Lymphocytic_B\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITPR1 PTPRC CXCR4 BTK BANK1 PLD4 KIAA0040 CD79A	3.76e-06	174	232	8	cc493654ea3517bc6a145c7f787f304929636f86
ToppCell	LPS-antiTNF-Lymphocytic_B-B_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITPR1 PTPRC CXCR4 BTK BANK1 PLD4 KIAA0040 CD79A	3.76e-06	174	232	8	b4c2d1c029fcd0d4926aa79a5b789c713919dcf3
ToppCell	droplet-Lung-nan-21m-Lymphocytic-plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUGGC ZPBP2 RAB39B CMAHP PRDX4 ASNS CD79A KBTBD12	3.76e-06	174	232	8	fad66d1a8407574b6a835e0bdb824a53afa58650
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(II)\|lymph-node_spleen / Manually curated celltypes from each tissue	NUGGC AICDA MED12L DMD KNL1 IGF2BP3 ABCA6 SYTL4	4.09e-06	176	232	8	5788dd5b23ebb52f19d3b5bdbcfe25dee349cf77
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-Plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUGGC TMEM214 RAB39B CMAHP EPM2A PRDX4 CD79A KBTBD12	4.09e-06	176	232	8	606704098bfdf8bfef740a3544a372fae1e75969
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	BTK DMD BANK1 KNL1 FAM72C LIMS2 CD79A FZD2	4.09e-06	176	232	8	052b54c4337ca728974a106b6dbd3b72dd28eb23
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUGGC TMEM214 RAB39B CMAHP EPM2A PRDX4 CD79A KBTBD12	4.09e-06	176	232	8	acb9e29773030f6452a069f8f7e53eab68ab7bd3
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-naive_B_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MYO7B PTPRC BANK1 COL19A1 LIMS2 KIAA0040 CD79A IL2RG	4.27e-06	177	232	8	325c10674b18727ddd50bf088a9c6f4ef29aa809
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYO7B BTK ZPBP2 DMD BANK1 PLD4 COL19A1 CD79A	4.45e-06	178	232	8	812e261d9cbdc74fafe3c5c3422151c1cfacb22d
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP NBEAL1 VPS13C KDR TASOR AKAP9 TNKS STAG2	4.45e-06	178	232	8	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	RV-11._Adipocyte\|RV / Chamber and Cluster_Paper	TMEM241 MYCBP2 FASN NWD2 GPAM PLAAT3 PPIP5K1 PLAAT5	4.45e-06	178	232	8	278bbea5cf8f0589f71675c7a3d00679391b5253
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CCDC168 COL22A1 PLXND1 CNTNAP5 NWD2 CMAHP SATB2 RORB	4.45e-06	178	232	8	0e1bedf991189d0ef9b40dac9281bdf4739333a1
ToppCell	droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP KDR EXOC6 UACA DGKE LIMS2 DOK4 TANC1	5.03e-06	181	232	8	92d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYO7B CXCR4 DMD BANK1 PLD4 COL19A1 LIMS2 CD79A	5.03e-06	181	232	8	ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITPR1 CXCR4 BTK BANK1 PLD4 COL19A1 KIAA0040 CD79A	5.03e-06	181	232	8	0c52dd82e6b3dce3d6bb5c13501bf8383f7121e4
ToppCell	droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP KDR EXOC6 UACA DGKE LIMS2 DOK4 TANC1	5.24e-06	182	232	8	81279877b920b5a1bc991a07d3031d6458700fe3
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NLRP11 NUGGC DCHS2 MYO7B LRGUK ACSBG2 SATB2 COL19A1	5.46e-06	183	232	8	d73cac83cde82665f110baad7cf28db75f9ffe52
ToppCell	droplet-Kidney-nan-24m-Lymphocytic-CD45____plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUGGC ATP6V0A1 RCBTB2 CMAHP PRDX4 ASNS CD79A KBTBD12	5.46e-06	183	232	8	edb0069c66b1465dcc0bb5881417c6b17184fd74
ToppCell	droplet-Mammary_Gland-nan-18m-Lymphocytic-B_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUGGC CXCR4 BTK CMAHP BANK1 PLD4 CD79A KBTBD12	5.68e-06	184	232	8	73ddf9d647d61381bab1e9c0d983736b6d390c15
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TXK PTPRC CXCR4 BTK CMAHP BANK1 CD79A IL2RG	5.68e-06	184	232	8	5cf7447faaec99fc37dfa8e92ff72cc2c7c05951
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TXK PTPRC CXCR4 BTK CMAHP BANK1 CD79A IL2RG	5.68e-06	184	232	8	7126261a453c7e2f3f005016873b6adeb51e46f8
ToppCell	(1)_B_CD27neg\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	MYO7B PTPRC CXCR4 BTK BANK1 COL19A1 CD79A IL2RG	6.15e-06	186	232	8	646389147189760e9493c4f50f9583959ef0ee26
ToppCell	(1)_B_cells\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	TRAF5 PTPRC CXCR4 BTK BANK1 COL19A1 CD79A IL2RG	6.15e-06	186	232	8	fe0f8e99ca766e004c351835fdbc2dc888dceb62
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	INTU PTGFR YAE1 ANK3 KRBA2 SF3B3 SYTL4 PPIP5K1	6.39e-06	187	232	8	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-naive_B_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MYO7B PTPRC BANK1 COL19A1 LIMS2 KIAA0040 CD79A IL2RG	6.65e-06	188	232	8	31129152386e9aba16f749d78da12a08b916e6f8
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ITPR1 ZNF462 UBR5 RAD54B ANK3 PRIM2 TANC1 IL17RD	6.65e-06	188	232	8	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	Healthy-B_naive\|World / disease group, cell group and cell class	TRAF5 CXCR4 DMD BANK1 COL19A1 ABCA6 KIAA0040 CD79A	6.91e-06	189	232	8	1e533a43f739ff295740cf2b25479756dfb8e595
ToppCell	wk_15-18-Hematologic_Lymphocytic-B-CD5-_Mature_B\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYO7B PTPRC CXCR4 BTK BANK1 COL19A1 KIAA0040 CD79A	7.18e-06	190	232	8	ade43d1d1f8909b8526a23152acf3c26f160f836
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRAF5 PTPRC CXCR4 BTK BANK1 PLD4 CD79A IL2RG	7.18e-06	190	232	8	0d0921d67707aea608f52cbb35e54a3892eeffad
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TRAF5 MYCBP2 MYO7B ITPR1 CXCR4 BANK1 COL19A1 CD79A	7.18e-06	190	232	8	a7498fe55b7810c482291db782dc5282675d246a
ToppCell	COVID-19_Severe-B_intermediate\|World / disease group, cell group and cell class	MYO7B IFI44L DMD BANK1 COL19A1 LIMS2 KIAA0040 CD79A	7.47e-06	191	232	8	f226fd69a26124ba98e4544f550b89a08e6a3708
ToppCell	Mild/Remission-B_naive-11\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	VPS13C RPS12 PTPRC CXCR4 IFI44L BANK1 COL19A1 CD79A	7.47e-06	191	232	8	ebb165096de301ba663703d1662d9413ea317867
ToppCell	B_cells-Memory_B_cells\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	ITPR1 PTPRC CXCR4 BTK BANK1 COL19A1 CD79A IL2RG	7.76e-06	192	232	8	eef591095921ede098f41a2b81897b18915bb753
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	RALGAPA1 NBEAL1 CLTC ANKRD50 THOC2 AKAP9 WDFY3 STAG2	8.06e-06	193	232	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TRAF5 MYCBP2 MYO7B VPS13C ITPR1 BANK1 COL19A1 CD79A	8.37e-06	194	232	8	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NBEAL1 RPS12 CXCR4 BANK1 PLD4 COL19A1 KIAA0040 CD79A	8.37e-06	194	232	8	a778b5d1f7661c29dc8d894827891c1036255749
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TRAF5 CXCR4 BTK IFI44L BANK1 COL19A1 KIAA0040 CD79A	8.37e-06	194	232	8	83554ba6a789750a39af58537fd7044ce20d3f02
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TRAF5 CXCR4 BTK IFI44L BANK1 COL19A1 KIAA0040 CD79A	8.37e-06	194	232	8	56286db641cfb270e52f33989b8bf7b14d45010a
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-CD5-_Mature_B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MYO7B PTPRC CXCR4 BTK BANK1 COL19A1 KIAA0040 CD79A	8.69e-06	195	232	8	fe3f978820a63c26a537d97e69f7999dd60bb0ea
ToppCell	NS-critical-LOC-Lymphoid-B_cell\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TRAF5 MYCBP2 NBEAL1 RPS12 BTK BANK1 PLD4 CD79A	8.69e-06	195	232	8	1c0d8dbe8490c35903061469e395b218416b1aa2
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-B_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRAF5 AICDA PTPRC CXCR4 BTK BANK1 COL19A1 CD79A	8.69e-06	195	232	8	e3df097e894b96b7d23db35bd527a8de6a055e52
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RPS12 PTPRC CXCR4 BTK BANK1 PLD4 COL19A1 CD79A	9.01e-06	196	232	8	afd39d6d22d72d6b674a63d389a21f6dea6b9f20
ToppCell	COVID-19_Severe\|World / disease group, cell group and cell class	ADM IFI44L THBS1 IGF2BP3 LIMS1 SYTL4 PRKAR1B HERC5	9.01e-06	196	232	8	3bedf60f662b373ad9d0f07d4da9f11864af3a74
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RPS12 PTPRC CXCR4 BTK BANK1 PLD4 COL19A1 CD79A	9.01e-06	196	232	8	cbccad6f554d5ec1ec22988f74362b5a69fc56d0
ToppCell	control-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TRAF5 CXCR4 BTK BANK1 PLD4 COL19A1 KIAA0040 CD79A	9.36e-06	197	232	8	559650fb53f18ecae4cfaa8221e978ae3fb63e06
ToppCell	mLN-B_cell-B_cell_cycling\|mLN / Region, Cell class and subclass	AICDA MELK ADM RAD54B MED12L DMD LIMS2 PALLD	9.36e-06	197	232	8	806dddcca85c82bd642008d930c8db16b613d88e
ToppCell	mLN-B_cell-B_cell_cycling\|B_cell / Region, Cell class and subclass	AICDA MELK ADM RAD54B MED12L DMD LIMS2 PALLD	9.36e-06	197	232	8	2071526fe46de8359ea118ff78581eb4454aa55a
ToppCell	Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRABD2B MS4A4E KDR IFI44L UACA ABCA6 KBTBD12 IL17RD	9.36e-06	197	232	8	6806ec223e542f0475303698eb78c1cc527f5c6b
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRC CXCR4 BTK BANK1 PLD4 COL19A1 CD79A IL2RG	9.36e-06	197	232	8	0e56255862fed099e771ebd2529393dc5a3641ba
ToppCell	mLN-(2)_B_cell-(24)_B_cell_cycling\|mLN / shred on region, Cell_type, and subtype	AICDA MELK ADM RAD54B MED12L DMD LIMS2 PALLD	9.36e-06	197	232	8	70fff2d6723f259e18e7a21d22dc46d71f0759ce
ToppCell	Biopsy_IPF-Immune-B_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	TRAF5 PTPRC CXCR4 BANK1 PLD4 COL19A1 CD79A IL2RG	9.71e-06	198	232	8	6a519337a4932a7b685fe7defd3de24fa2016b7d
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	STXBP1 KDR PLEC EXOC6 UACA ANKRD50 LIMS2 TANC1	1.01e-05	199	232	8	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	VPS13C PSMD12 GALNT7 NIPBL THOC2 LIMS1 AKAP9 STAG2	1.01e-05	199	232	8	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	distal-2-Hematologic-Natural_Killer_T\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KRT72 RCBTB2 PTPRC CXCR4 KLRC2 KLRC3 RNF17 IL2RG	1.01e-05	199	232	8	f89165dab4a75ef5d93bf0f047fc61099442db35
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 ACACA UBR5 DMD COG5 ANK3 TNKS WDFY3	1.01e-05	199	232	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	distal-Hematologic-Natural_Killer_T-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KRT72 RCBTB2 PTPRC CXCR4 KLRC2 KLRC3 RNF17 IL2RG	1.01e-05	199	232	8	cf9c5b2a7d2b53d06d2f8edd1b2d12b6719ebfef
ToppCell	343B-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FZD1 ADM NUAK1 LIMS1 AKAP9 ABCA6 KIAA0040 TANC1	1.01e-05	199	232	8	212e89d097753790061310373a1fafba773488b6
ToppCell	343B-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FZD1 ADM NUAK1 LIMS1 AKAP9 ABCA6 KIAA0040 TANC1	1.01e-05	199	232	8	14b676aa289c0578a37be32cec3ea285c79d97cc
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	PSMD12 GALNT7 ADM NIPBL THOC2 LIMS1 AKAP9 PALLD	1.01e-05	199	232	8	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	Neuronal-Excitatory-eC(RORB)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CCDC168 PLXND1 NWD2 NUAK1 RAD54B CMAHP SATB2 RORB	1.04e-05	200	232	8	8c803a0ce25e140b46036f6aabefc5502601f408
ToppCell	normal_Lung-Endothelial_cells-Stalk-like_ECs\|Endothelial_cells / Location, Cell class and cell subclass	MYCBP2 RPS12 ITPR1 NUAK1 IFI44L EXOC6 LIMS2 PALLD	1.04e-05	200	232	8	413ac64bbe95b8c921c5396d8b5f298fec8c4f82
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RALGAPA1 NUAK1 CXCR4 AKR1B10 EXOC6 LIMS2 ASNS PALLD	1.04e-05	200	232	8	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-B\|Multiple_Sclerosis / Disease, condition lineage and cell class	TRAF5 CXCR4 BTK BANK1 PLD4 COL19A1 KIAA0040 CD79A	1.04e-05	200	232	8	082b3be49fa9d65ed8351d4e80680583f8735207
ToppCell	P07-Hematopoietic-Immune\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TXK PTPRC BTK BANK1 PLD4 CYP2R1 CD79A	1.07e-05	144	232	7	962698c5c15bd583fccda0593b7aab5f2eb4bc9f
ToppCell	P07-Hematopoietic-Immune-immune_cell_unspecified\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TXK PTPRC BTK BANK1 PLD4 CYP2R1 CD79A	1.07e-05	144	232	7	eb057dbdb2a5a2d29b93e5ed5479a3fd1bf3fd26
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	TRAF5 ITPR1 DES DMD CAP2 KBTBD12 PALLD	1.58e-05	153	232	7	ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NLRP11 AICDA UBR5 BTK KNL1 THSD7B IGF2BP3	1.80e-05	156	232	7	203ef22eb76bd2b829b027c30af0557080f4006c
ToppCell	facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUGGC ATAD5 RAD54B BANK1 KNL1 CYP2R1 CD79A	1.87e-05	157	232	7	0fecc14959c4c9efc19d5c06475a890e0a30f148
Disease	superior crus of antihelix expression	BANK1 XPNPEP1	5.84e-05	2	226	2	EFO_0007673
Disease	severe combined immunodeficiency (is_implicated_in)	PTPRC RFXANK IL2RG	1.52e-04	14	226	3	DOID:627 (is_implicated_in)
Disease	Microcephaly and chorioretinopathy	TUBGCP4 TUBGCP6	1.74e-04	3	226	2	cv:CN263236
Disease	Autosomal recessive chorioretinopathy-microcephaly syndrome	TUBGCP4 TUBGCP6	1.74e-04	3	226	2	cv:C3502492
Disease	Microcephaly with Chorioretinopathy, Autosomal Recessive	TUBGCP4 TUBGCP6	1.74e-04	3	226	2	C3502492
Disease	nasopharynx carcinoma (is_marker_for)	DAB2IP CXCR4 KDR RAD52	3.27e-04	43	226	4	DOID:9261 (is_marker_for)
Disease	sphingosine 1-phosphate measurement	ITPR1 DMD UBE2O	3.32e-04	18	226	3	EFO_0800185
Disease	chromosomal aberration frequency	UBR5 COPB1 OR10J5	3.32e-04	18	226	3	EFO_0009860
Disease	cognitive decline measurement, disease progression measurement	PARP6 UBR5	3.47e-04	4	226	2	EFO_0007710, EFO_0008336
Disease	neurilemmoma (is_marker_for)	ATAD5 KDR	5.75e-04	5	226	2	DOID:3192 (is_marker_for)
Disease	muscular disease (implicated_via_orthology)	ACACA FASN	5.75e-04	5	226	2	DOID:0080000 (implicated_via_orthology)
Disease	Diffuse Large B-Cell Lymphoma	TRAF5 CLTC PRDX4 CD79A	8.42e-04	55	226	4	C0079744
Disease	Membranoproliferative Glomerulonephritis, Type I	ALB DGKE	8.58e-04	6	226	2	C0268742
Disease	laryngeal carcinoma (is_marker_for)	UBR5 CXCR4	8.58e-04	6	226	2	DOID:2600 (is_marker_for)
Disease	trefoil factor 1 measurement	TMPRSS3 TMPRSS4	8.58e-04	6	226	2	EFO_0021865
Disease	Membranoproliferative Glomerulonephritis, Type III	ALB DGKE	8.58e-04	6	226	2	C1720821
Disease	Periodontal Pocket	COL22A1 PTGFR IFI44L	9.00e-04	25	226	3	EFO_1001393
Disease	epidermolysis bullosa simplex (is_implicated_in)	PLEC CD151	1.20e-03	7	226	2	DOID:4644 (is_implicated_in)
Disease	pancreatic ductal carcinoma (is_marker_for)	TMPRSS3 ALB THBS1 PALLD	1.24e-03	61	226	4	DOID:3587 (is_marker_for)
Disease	retinal degeneration (biomarker_via_orthology)	PTPRC DMD ASNS	1.26e-03	28	226	3	DOID:8466 (biomarker_via_orthology)
Disease	hypertension, white matter hyperintensity measurement	NBEAL1 MS4A4E PNPT1 TNKS	1.32e-03	62	226	4	EFO_0000537, EFO_0005665
Disease	colorectal cancer (is_marker_for)	DAB2IP ADM FASN CXCR4 BTK THBS1	1.37e-03	157	226	6	DOID:9256 (is_marker_for)
Disease	COVID-19 (is_marker_for)	BTK ALB THBS1 IL2RG	1.40e-03	63	226	4	DOID:0080600 (is_marker_for)
Disease	fat body mass	MYCBP2 COL22A1 MED12L CAP2 COL19A1 TMPRSS4 CCDC171	1.48e-03	217	226	7	EFO_0005409
Disease	Myofibrillar Myopathy	PYROXD1 DES	1.59e-03	8	226	2	C2678065
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP5 CRBN	1.59e-03	8	226	2	DOID:0060308 (implicated_via_orthology)
Disease	Bright Disease	ADM DES ALB	1.70e-03	31	226	3	C1704377
Disease	Glomerulonephritis	ADM DES ALB	1.70e-03	31	226	3	C0017658
Disease	Muscular Dystrophies, Limb-Girdle	DES PLEC LIMS2	1.87e-03	32	226	3	C0686353
Disease	lysophosphatidylcholine 20:4 measurement	MYCBP2 FADS1 TNKS	1.87e-03	32	226	3	EFO_0010363
Disease	Mental Retardation, X-Linked 1	ACSL4 RAB39B DMD	1.87e-03	32	226	3	C2931498
Disease	symmetrical dimethylarginine measurement	AKR1B10 AKR1B15	2.03e-03	9	226	2	EFO_0006523
Disease	stomach cancer (is_implicated_in)	DAB2IP CXCR4 KDR TEP1	2.29e-03	72	226	4	DOID:10534 (is_implicated_in)
Disease	mean platelet volume	ARHGAP32 ATAD5 PLXND1 TXK ACSL4 PTPRC PLEC CMAHP TASOR BANK1 EPM2A TRMU FRY LIMS1 FADS1 SYTL4 CD151	2.34e-03	1020	226	17	EFO_0004584
Disease	serum IgG glycosylation measurement	INTU VPS13C PTGFR PNPT1 CNTNAP5 COL19A1 EFCAB6 FRY IGF2BP3 ERCC6L2 CRBN	2.48e-03	523	226	11	EFO_0005193
Disease	obstructive jaundice (biomarker_via_orthology)	ADM ALB	2.52e-03	10	226	2	DOID:13603 (biomarker_via_orthology)
Disease	lean body mass	ATAD5 VPS13C ZNF462 PLEC TASOR GPAM IGF2BP3 SYTL4 MAPKBP1	2.73e-03	379	226	9	EFO_0004995
Disease	early infantile epileptic encephalopathy (implicated_via_orthology)	STXBP1 IDH3G	3.07e-03	11	226	2	DOID:0050709 (implicated_via_orthology)
Disease	Hemolytic-Uremic Syndrome	ALB DGKE	3.07e-03	11	226	2	C0019061
Disease	level of Sterol ester (27:1/20:5) in blood serum	NWD2 FADS1	3.07e-03	11	226	2	OBA_2045197
Disease	response to risperidone	CNTNAP5 PACC1 HMGXB3	3.07e-03	38	226	3	GO_0097336
Disease	white matter integrity	TRABD2B NBEAL1 TRAPPC13 NUAK1 CRBN	3.33e-03	130	226	5	EFO_0004641
Disease	Agammaglobulinemia	BTK CD79A	3.66e-03	12	226	2	C0001768
Disease	metabolite measurement	CLTCL1 ZNF462 PNPT1 AKR1B10 DMD ANK3 GPAM BABAM2 TUBGCP6 FADS1 RFXANK	4.15e-03	560	226	11	EFO_0004725
Disease	liver fat measurement	NUAK1 PLEC GPAM	4.37e-03	43	226	3	EFO_0010821
Disease	immunoglobulin isotype switching measurement	KLRC2 KLRC3 UBR4	4.66e-03	44	226	3	EFO_0010128
Disease	Familial dilated cardiomyopathy	DES DMD CAP2	4.66e-03	44	226	3	C0340427
Disease	bipolar I disorder	PLEC ANK3 XPNPEP1 BABAM2 FADS1	4.70e-03	141	226	5	EFO_0009963
Disease	respiratory quotient	INTU TOMM20	5.00e-03	14	226	2	EFO_0005189
Disease	Nephrosis	DES ALB	5.74e-03	15	226	2	C0027720
Disease	mean fractional anisotropy measurement	TRAPPC13 NUAK1 PLEC WDFY3	6.20e-03	95	226	4	EFO_0008399
Disease	developmental disorder of mental health (implicated_via_orthology)	DAB2IP PLXND1 TANC1	6.30e-03	49	226	3	DOID:0060037 (implicated_via_orthology)
Disease	Diabetic Angiopathies	ALB THBS1	6.53e-03	16	226	2	C0011875
Disease	Microangiopathy, Diabetic	ALB THBS1	6.53e-03	16	226	2	C0025945
Disease	bilirubin measurement	DCHS2 PYROXD1 ALB CMAHP EXOC6 GPAM ANKRD50 USP40 CCDC171	7.34e-03	442	226	9	EFO_0004570
Disease	Bardet-Biedl syndrome 1 (disorder)	BBS4 MKS1	7.36e-03	17	226	2	C2936862
Disease	eicosapentaenoate EPA; 20:5n3 measurement	FZD1 FADS1	7.36e-03	17	226	2	EFO_0021049
Disease	Hypogammaglobulinemia	BTK CD79A	7.36e-03	17	226	2	C0086438

Protein segments in the cluster

Peptide	Gene	Start	Entry
AEVCQYVITHAKVNI	ACSBG2	141	Q5FVE4
VHVNVYCDGIVKATT	BANK1	261	Q8NDB2
LLDISCVKHIIYVDN	ACSL4	216	O60488
VQLVCSEHGLDNKIY	ATAD5	1426	Q96QE3
ILHLYDKGGIEQTIC	ASNS	101	P08243
EISHNLGVCYIYLKQ	BBS4	136	Q96RK4
EHYVAVQLLKEECGT	AKAP9	2856	Q99996
QQRLKAAVHYTVGCL	CENPS	16	Q8N2Z9
YLSVVLNQLCVLHEK	ALB	476	P02768
LFCNQEHKVIIVGLD	ARL5B	11	Q96KC2
NFLCKAVHVIYTVNL	CXCR4	106	P61073
NLSHEKLVQLYGVCT	BTK	451	Q06187
VAQYSGKHQVQCHLI	CTSL3P	171	Q5NE16
AEKYCQLENAHLVVI	ASGR2	201	P07307
AKQLQHISGIGVTCY	ABCA12	2016	Q86UK0
HTLYQHLVAGCVLIK	CCDC171	571	Q6TFL3
VIIASCLHKEYAGQK	ABCA6	1276	Q8N139
EQKHTYLPLEVCNIV	AGO1	331	Q9UL18
NKNGCHVELLFLRYI	AICDA	51	Q9GZX7
VQIKCFHEIITIGYN	CDS2	101	O95674
VHETLTVYKACNLNL	CRBN	356	Q96SW2
YGHQFCIENLQKLIL	ACACA	1111	Q13085
LTQEKLIQYCHSKGI	AKR1B10	191	O60218
NCVDIYNHAKFLGVT	BTBD11	1026	A6QL63
GHYDCVQILLENKSN	ANKRD50	891	Q9ULJ7
VNKSHGGIYVCRVQE	CD79A	96	P11912
EVVQSQLNHCVNLYK	DMD	1496	P11532
LPCLQVGQEQKHTYL	AGO3	326	Q9H9G7
VGQEQKHTYLPLEVC	AGO3	331	Q9H9G7
KHTYLPLEVCNIVAG	AGO3	336	Q9H9G7
RFGTCTVQKLAHQIY	ADM	111	P35318
CESLNIVHNYILPSK	NWD2	391	Q9ULI1
ACYILGKLEHVLSQS	NBEAL1	1611	Q6ZS30
QTLNILQEVCKRHGY	RAD54B	671	Q9Y620
NKQVIEVACGSYHSL	RCBTB2	151	O95199
VQPYQIVFVLVGHKC	RAB39B	111	Q96DA2
NVSCYLEGKQIHGEQ	OSMR	176	Q99650
NFTYLCQIELHGEGK	OSMR	361	Q99650
QKVCYIEGHRVINLA	RAD52	61	P43351
GVVYTSHLQLKEKCN	RGPD5	491	Q99666
GVVYTSHLQLKEKCN	RGPD8	491	O14715
QAITDHYIQVLNCKQ	P3H1	266	Q32P28
VLEKYCEASGQFIHQ	KIAA0895L	176	Q68EN5
VCVIDCQTGIVLHKY	LRWD1	321	Q9UFC0
HVDFVQKGYTLKCQT	MELK	586	Q14680
VIKPVHSSILGQDYC	DAB2IP	156	Q5VWQ8
KQLTVKECEYLIGQH	FBXO21	356	O94952
KECEYLIGQHVTAAL	FBXO21	361	O94952
VILTYHDIGLNHKSC	NDRG3	56	Q9UGV2
LEKGHIVYVHCNAGV	EPM2A	256	O95278
DNCTTYLNPVGKHVI	IL17RD	61	Q8NFM7
GILKYTHNDAIQCVS	IFT122	86	Q9HBG6
GKYICQRCHLVIDEQ	LIMS2	136	Q7Z4I7
LYTTLCIEQHQLNKE	MCU	186	Q8NE86
HECNQRTILLYGVGK	MED12L	721	Q86YW9
HIYVLVNKLDLGCDA	MAGEB10	176	Q96LZ2
VHCIETHGRNVQYIK	ITPR1	1306	Q14643
CQILDIPFHQVSYVK	TRMU	61	O75648
VLDYSHCSLQQVPKE	LRRC7	26	Q96NW7
CVNRLKNYGVLHVTF	NLRP11	811	P59045
GIYIKQVVLCKFHSV	IBTK	176	Q9P2D0
KAIVLCHNVTPVYES	ATP9B	546	O43861
QVHKEVLNCGIAYVA	IFI44L	341	Q53G44
LTKHQEGIYNTICLG	KIAA0040	16	Q15053
EVEKHLVVNIGTHCY	CWF19L1	336	Q69YN2
LVVNIGTHCYLALAK	CWF19L1	341	Q69YN2
ISINKTEGCHIYLSE	CAP2	411	P40123
YSEEKLQHLLRQCGI	HMGXB3	1006	Q12766
IVIIEHKSIICPGYN	GSPT2	526	Q8IYD1
KVTAFQYGIVLLHCS	FBXW12	226	Q6X9E4
YSCVGVFQHGKVEII	HSPA2	16	P54652
YKLASQCCGVHVISL	PTGFR	316	P43088
HEYRVKIGQVSCDIQ	PLXND1	1211	Q9Y4D7
NVICIVYAVNNKHSI	RHOT1	76	Q8IXI2
VIVELIYKVCHANPS	COPB1	226	P53618
LEVHQFYPLVKVQCS	FZD2	71	Q14332
ICINDYEQHAKSVLP	HAO1	6	Q9UJM8
CTQLVDNLVEHILKY	NIPBL	1971	Q6KC79
HNIVYCGGVLDKQIT	KNL1	696	Q8NG31
QKIHGCQILETVYKH	TUBGCP4	146	Q9UGJ1
IAHDIYVCGKTINLL	TUBGCP6	591	Q96RT7
VISKTVDYLHCQGVV	RPS6KA6	526	Q9UK32
DVSILCGYVHLQKLD	LRGUK	141	Q96M69
IQLDQHEGSYLSICK	PSMD12	231	O00232
VQDIHSVGSLCKLYF	ARHGAP32	436	A7KAX9
IINTTHLEQACKYLE	EXOC6	551	Q8TAG9
VVKITGHFYACQVAQ	IGF2BP3	536	O00425
ENYSFLPLVHNIIKC	MED9	61	Q9NWA0
GQAQLLSCKHHYEVI	PACC1	121	Q9H813
GHRAYCKVAVLIQDE	DCHS2	2221	Q6V1P9
QEKKIIQITCGDYHS	HERC5	136	Q9UII4
DCVYVDQVKTTLHQL	INTU	621	Q9ULD6
DNHGYICLLIQGATK	PALLD	1286	Q8WX93
KELGAVIYNCSHLAQ	PLD4	241	Q96BZ4
ILDLVKGTHYQVACQ	PRIM2	411	P49643
YVLTQNDVKGCHLVG	KAT6A	616	Q92794
HALCKVIPYLQAVSV	HCRTR1	116	O43613
GVVYTSHLQLKEKCN	RGPD3	491	A6NKT7
AQGTDKLQCHITYLE	CCDC105	416	Q8IYK2
IYAVCGQVQHLQKVL	COG5	341	Q9UP83
HQFYPLVKVQCSAEL	FZD1	151	Q9UP38
LEVHQFYPLVKVQCS	FZD7	81	O75084
NEKCAIGVTHFQLVQ	GLG1	731	Q92896
LYANVIHCKSLPGVV	IDH3G	141	P51553
IKCSVLNSEEIHYVI	GNPAT	71	O15228
ECLLLVVKELVQQYH	BABAM2	111	Q9NXR7
ISKLAYHQGVVIVTC	DNLZ	86	Q5SXM8
ELACEQAHQYLVTKA	EFCAB6	831	Q5THR3
VDIELHQLKIYCSAN	COL19A1	221	Q14993
HQLKIYCSANLIAQE	COL19A1	226	Q14993
GYDVVKECLVHQSEI	CYP2R1	91	Q6VVX0
AKLGQVLIYLDAHCE	GALNT7	291	Q86SF2
KGIVCLINIIGIHYN	CYP4F11	416	Q9HBI6
DIACLKCGNIVVYHV	FAM72C	71	H0Y354
HIQAVTQEHAGKYIC	CDON	486	Q4KMG0
HQIQSYTCEIDALKG	DES	326	P17661
KGKAEVAVTLYQHVC	C1orf112	406	Q9NSG2
VIILIKSDSVHLYCN	DNAAF9	96	Q5TEA3
VGCHYGNIKIVNFLL	ANK3	736	Q12955
QAQRAGCKSVHYDLV	COL22A1	26	Q8NFW1
PLVQSLCAKHGIEYQ	FADS1	401	O60427
LGNIDVIHSYLCKGL	MS4A4E	21	Q96PG1
ITSGCQLQKKEIHLY	IL2RG	111	P31785
QVAELQEHKYGVACV	MAPKBP1	126	O60336
GCSYLQHIQIETGAK	KHDC4	256	Q7Z7F0
KGCELYVQLHGIQQV	PRKAR1B	16	P31321
YVQLHGIQQVLKDCI	PRKAR1B	21	P31321
GTVYLLLENHLCVQE	HCAR1	146	Q9BXC0
LFQSYCKLIGQVHEV	FRY	2841	Q5TBA9
LLCNGKNYSLHIEEQ	CCDC168	4911	Q8NDH2
GVYGSFHCAQIQVKL	DGKE	481	P52429
QIYKQQLHCVVVGSE	ERCC6L2	656	Q5T890
QLHCVVVGSENAKRY	ERCC6L2	661	Q5T890
LCGQRDHASNIYKVE	CD151	191	P48509
DYNLSQVCDGKVSVH	FASN	2461	P49327
GCSVQKLYEALQKHV	CGRRF1	101	Q99675
KIYNCHVLLNSKGAV	NIT1	141	Q86X76
VYGECKLQITHENIY	DOK4	151	Q8TEW6
VLLCKNGSLQVRYHL	CNTNAP5	1066	Q8WYK1
EVIVLYLTLCKQCHQ	KRBA2	226	Q6ZNG9
ILQKCHGLSIDGYVL	PHKA2	1091	P46019
HCKNIPTLEYGFLVQ	PARP6	256	Q2NL67
LVCVVFHSGAQEKNY	PCDH11Y	46	Q9BZA8
SKYEAILCIIHQATQ	PCARE	196	A6NGG8
YAVRGNHVKCVEALL	RFXANK	196	O14593
QALYPHVLVKNCAVE	HNRNPUL1	366	Q9BUJ2
LACHAVVTVNNKLYV	KBTBD12	426	Q3ZCT8
VVIVHCGCASIAYLK	OR10J5	246	Q8NHC4
CYIHTGQEGIVDIIK	FREM3	1386	P0C091
KHRAICGLQSQYEIE	FER1L6	1451	Q2WGJ9
IQIKDAIGRYHQCAT	TARS1	546	P26639
QSLVVHVKECHQLAY	SYTL4	371	Q96C24
AGVHVYNVKQLKLHC	UTP4	506	Q969X6
GVVYTSHLQLKEKCN	RGPD4	491	Q7Z3J3
HQTLKAVCLKNGIYA	NUGGC	546	Q68CJ6
LFHLGQYETCLKDIN	SMYD4	116	Q8IYR2
GQEVLYKLTSENCEH	PLAAT3	101	P53816
LVQAFQYTDKHGEVC	PRDX4	231	Q13162
NHQGIDKIYDCQGLL	KLRC2	51	P26717
KHCDNVLYQGLVEIL	RFX1	681	P22670
QITAACKHGGDLYVV	KBTBD4	276	Q9NVX7
QTHNKVITYAGCITQ	OR7A10	86	O76100
QVCHETVGKFIQYGI	GPAM	641	Q9HCL2
HYVVDGIDCLLAQKV	PRAMEF22	81	A3QJZ6
ISIGQGCAYKAIIEH	MEP1A	141	Q16819
VYHVVTLKIQLQSCS	SATB2	146	Q9UPW6
SNVLYCAEIKDIGHL	RNF227	171	A6NIN4
CLKGHRAVVQYLVEE	TANC1	1186	Q9C0D5
CVKGINARYVSVHVD	MYCBP2	3786	O75592
NHQGIDKIYDCQGLL	KLRC3	51	Q07444
QIVSAVHYCHKNGVV	NUAK1	161	O60285
CTGDYAKEHLAQLQE	PHYHIP	111	Q92561
LKTLILEGCQIHYSQ	PRAMEF1	351	O95521
TQCSEKLVQLILHEY	DRG2	196	P55039
EKIVNSNGELYHEQC	LIMS1	21	P48059
ILGYCAENHLDIVLK	MROH2B	656	Q7Z745
FCHAIKVGVKYTQQI	PNPT1	241	Q8TCS8
KHYQGTVDKLCRVEQ	STXBP1	356	P61764
CNAKVILGRYQDHLQ	TRAF5	116	O00463
VDRYQVQTICEKGLH	TASOR	186	Q9UK61
LTQEKLIQYCHSKGI	AKR1B15	191	C9JRZ8
DTCIIVEYKGHKILN	CMAHP	166	Q9Y471
VEYKGHKILNIVDCT	CMAHP	171	Q9Y471
YLKQQCHAQKIGIVG	CMBL	116	Q96DG6
ICVQVASKYHEQLST	CLTC	681	Q00610
LCEKAGLLQQALEHY	CLTCL1	616	P53675
LCVQVASKYHEQLGT	CLTCL1	681	P53675
DVHLKYIQAACKTGQ	CLTCL1	726	P53675
KGKTAECTQYQQILH	SS18L1	41	O75177
QSLYNKELPVHICNV	RNF17	911	Q9BXT8
SNKICNHRDVYGGII	TMPRSS3	366	P57727
TVSHKCLVVGLEQYE	TNRC18	2916	O15417
VHKEGYNELNQCLTT	ZNF431	156	Q8TF32
TNYIGHKTKDLQAIC	THBS1	256	P07996
EHNVLVVEGARKYAC	ZBTB5	601	O15062
NNYHLTCRDVIGKEL	XPNPEP1	586	Q9NQW7
VGKLYDQCHDTLVQF	THOC2	766	Q8NI27
KHGGVCAVYVVNITQ	TRMT61B	351	Q9BVS5
GLSVNVVKYIHEKEC	WDFY3	246	Q8IZQ1
TEKSVLNCIYKVLHG	RALGAPA1	1421	Q6GYQ0
RVLQTKAHQYQITGC	TEP1	1751	Q99973
YEHVLCTLKVDSNGV	MKS1	221	Q9NXB0
ELYLQQKILCELSGH	THAP9	796	Q9H5L6
CIVTEDGNQHVYKKL	PYROXD1	96	Q8WU10
ICQHYLTNVNTTVKE	STAG2	771	Q8N3U4
LIKHYNCGDLSAVIF	TRABD2B	251	A6NFA1
KALVQCVHSVYIPNK	SPATA20	716	Q8TB22
GHVDIAALLIKYNTC	TNKS	881	O95271
QHTKILTGEQSYKCE	ZNF721	646	Q8TF20
IAQNIIKSHLETCQY	RORB	226	Q92753
LHGYRICIQAILQDK	TMEM214	216	Q6NUQ4
NCIIYPVNSKDLQHI	UBE2O	181	Q9C0C9
IQIDGHIYQCLECKQ	ZNF322	36	Q6U7Q0
SIQYDKQHVCGGSIL	TMPRSS4	221	Q9NRS4
YVKLVEALCAEHQIN	RPS12	61	P25398
LSLNVGCIQIVYLHK	VPS13C	1181	Q709C8
LSFKVGCIQIVYVHK	VPS13C	1696	Q709C8
DGVRGIYKLLCQQHA	PHF11	146	Q9UIL8
LLAVCDYKQVEVTVH	PLEC	946	Q15149
CENKHIANYISGIQT	SF3B3	981	Q15393
CLELYKVVQGHRQLD	UBA1	906	P22314
SIHVYCVDNILVKVA	UAP1	246	Q16222
LHNVAEVIICGYQKC	TMEM241	101	Q24JQ0
VFHVVTSKGNLECLN	UACA	71	Q9BZF9
KAIYHTLNLCNIDVT	ATP6V0A1	301	Q93050
GQCEEYVLKHLKSIT	YAE1	111	Q9NRH1
LAAKLGVNYVHQFCV	ZSWIM8	1706	A7E2V4
LSHSKLVQLYGVCIQ	TXK	321	P42681
CGHENLHLKIGYTNV	ZNF208	106	O43345
LHLKIGYTNVDECKV	ZNF208	111	O43345
QHCDYGNRTVKGVLI	ZNF462	1196	Q96JM2
CLYAVAPSKVNVHVL	TTC37	726	Q6PGP7
TLEHLICYSFQVAKG	KDR	1001	P35968
EYSECGKIFNQHILL	ZNF713	236	Q8N859
NKIVQYSLIEGNCEH	PLAAT5	221	Q96KN8
LDLKNQVHEAVPCYS	THSD7B	1041	Q9C0I4
VKEIGTHILVCAVSY	TRAPPC13	136	A5PLN9
ALTTVKPYCNEIHAQ	UBR4	4041	Q5T4S7
IYITCHLKVTLAEQD	POMZP3	116	Q6PJE2
LTELKHGDQEICAQY	PTPRC	1061	P08575
LYHGTIVNQIVCKEC	USP40	161	Q9NVE5
VVTAGSAILQKCHFY	VIRMA	546	Q69YN4
YEKGVDHLTNAIAVC	TOMM20	86	Q15388
CVKYDVQHNGSLGLQ	PPIP5K1	741	Q6PFW1
KIYVELHQNSPVLIC	ZPBP2	41	Q6X784
VCSLKHVAYVFQALI	UBR5	1941	O95071
KVTHILNVAYGVENA	DUSP19	91	Q8WTR2
KCLYEGEITQIQSHI	KRT72	261	Q14CN4
KCLYDAEIAQIQTHA	KRT74	276	Q7RTS7
LQDEVYCQILKQLTH	MYO7B	1706	Q6PIF6